2027 Intern, Data Management
Moderna
Summary
Individual-contributor intern opportunity based at Moderna's Binney Street location in Cambridge, Massachusetts, from January 19, 2027 – June 25, 2027. Applicants must be available for the full duration of the intern term.
Job description
You will gain meaningful, hands-on experience supporting Data Management Leads across the clinical study lifecycle in a regulated biopharmaceutical environment, contributing to the quality, integrity, and operational execution of clinical data through data review, documentation, testing, reconciliation, quality control, and study coordination activities.
Here's What You'll Do
- Partner with experienced Data Management Leads to learn and apply GxP regulations to clinical data collection.
- Provide operational support to Data Management Leads throughout the clinical study lifecycle.
- Perform hands-on clinical data review to identify inconsistencies and errors and conduct trend analysis to support data quality.
- Support documentation, testing, reconciliation, quality control, and study coordination activities.
- Adhere to Good Documentation Practices (GDP) and Data Integrity requirements to maintain accurate, complete, and inspection-ready records.
- Help enable Data Management Leads to dedicate greater capacity to study strategy, risk management, vendor oversight, cross-functional decision-making, and achievement of key study milestones.
- Complete all required training assignments in a timely manner.
- Contribute to special projects and continuous improvement initiatives as assigned.
- Build practical experience working within a regulated biopharmaceutical environment and contribute to ongoing clinical and operational initiatives.
- Gain exposure to opportunities for responsible use of digital and Generative AI tools to enhance productivity, learning, and operational workflows within appropriate regulated processes.
Here's What You'll Need (Basic Qualifications)
- Currently enrolled in a Bachelor's or Master's degree program in life sciences, health sciences, data sciences, or related analytical field.
- Candidates must already hold work authorization in US and be able to maintain that status without the need for future sponsorship.
Here's What You'll Bring to the Table (Preferred Qualifications)
- GPA of 3.3 (on a 4.0 scale) or equivalent academic achievement.
- Demonstrated ability to work independently while contributing effectively within a team environment.
- Strong written and verbal communication skills.
- High attention to detail and commitment to quality and compliance.
- Interest in working within clinical study environment under Good Clinical Practices.
- A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.
Requirements
- Currently enrolled in a Bachelor's or Master's degree program in life sciences, health sciences, data sciences, or related analytical field
- Must already hold work authorization in US and maintain status without future sponsorship
- GPA of 3.3 (on a 4.0 scale) or equivalent academic achievement
- Demonstrated ability to work independently while contributing effectively within a team environment
- Strong written and verbal communication skills
- High attention to detail and commitment to quality and compliance
- Interest in working within clinical study environment under Good Clinical Practices
Benefits
- Meditation & Mindfulness Classes
- Subsidized Commuter Benefits
- Paid Time Off
- Sick Time
- Holidays
- Volunteer Days
- Year-End Shutdown
- Location-Specific Perks
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.